JP5319691B2 - プラジカンテル、マクロライドラクトン、シクロデキストリンおよび粘稠化剤を含む駆虫ペースト - Google Patents

プラジカンテル、マクロライドラクトン、シクロデキストリンおよび粘稠化剤を含む駆虫ペースト Download PDF

Info

Publication number
JP5319691B2
JP5319691B2 JP2010533558A JP2010533558A JP5319691B2 JP 5319691 B2 JP5319691 B2 JP 5319691B2 JP 2010533558 A JP2010533558 A JP 2010533558A JP 2010533558 A JP2010533558 A JP 2010533558A JP 5319691 B2 JP5319691 B2 JP 5319691B2
Authority
JP
Japan
Prior art keywords
weight
paste
cyclodextrin
paste according
praziquantel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2010533558A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011503140A5 (https=
JP2011503140A (ja
Inventor
ビーラント−ベルクハウゼン，ズザンネ・クリステイーネ
オツペル，カトリン
ハース，シユテフアン
Original Assignee
ノバルティス アーゲー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ノバルティス アーゲー filed Critical ノバルティス アーゲー
Publication of JP2011503140A publication Critical patent/JP2011503140A/ja
Publication of JP2011503140A5 publication Critical patent/JP2011503140A5/ja
Application granted granted Critical
Publication of JP5319691B2 publication Critical patent/JP5319691B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP2010533558A 2007-11-15 2008-11-12 プラジカンテル、マクロライドラクトン、シクロデキストリンおよび粘稠化剤を含む駆虫ペースト Expired - Fee Related JP5319691B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07120767 2007-11-15
EP07120767.4 2007-11-15
PCT/EP2008/065335 WO2009062939A1 (en) 2007-11-15 2008-11-12 Anthelmintic paste comprising praziquantel, a macrolide lactone, cyclodextrin and a thickener

Publications (3)

Publication Number Publication Date
JP2011503140A JP2011503140A (ja) 2011-01-27
JP2011503140A5 JP2011503140A5 (https=) 2012-01-05
JP5319691B2 true JP5319691B2 (ja) 2013-10-16

Family

ID=39092818

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010533558A Expired - Fee Related JP5319691B2 (ja) 2007-11-15 2008-11-12 プラジカンテル、マクロライドラクトン、シクロデキストリンおよび粘稠化剤を含む駆虫ペースト

Country Status (7)

Country Link
US (1) US20100286154A1 (https=)
EP (1) EP2219643B1 (https=)
JP (1) JP5319691B2 (https=)
AU (1) AU2008322995B2 (https=)
CA (1) CA2703008A1 (https=)
ES (1) ES2385126T3 (https=)
WO (1) WO2009062939A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201041508A (en) * 2009-04-30 2010-12-01 Dow Agrosciences Llc Pesticide compositions exhibiting enhanced activity
GB2482526A (en) * 2010-08-05 2012-02-08 Fiona Anne Macdonald Praziquantel suspendable powder as an immersion fish treatment for parasites
EP2594258B1 (en) 2011-11-18 2020-03-18 Veterinärmedizinische Universität Wien Oral gel comprising praziquantel
WO2015064680A1 (ja) * 2013-10-30 2015-05-07 大蔵製薬株式会社 服用し易いゼリー状医薬組成物
GB2527555B (en) 2014-06-25 2018-09-19 Norbrook Lab Ltd Stable methimazole liquid compositions
RU2613490C2 (ru) * 2015-01-27 2017-03-16 Общество с ограниченной ответственностью "Научно-производственная компания "СКиФФ" Композиция на основе R(-)-празиквантела для лечения и профилактики гельминтозов у теплокровных
CA3033065A1 (en) 2016-08-11 2018-02-15 Adamis Pharmaceuticals Corporation Drug compositions
US11564910B2 (en) 2017-12-08 2023-01-31 Adamis Pharmaceuticals Corporation Drug compositions
DE102018002904A1 (de) 2018-04-09 2019-10-10 Marc de Cocq Die Verwendung von Praziquantel in Kombination mit Milbemycinen zur Behandlung von Fischen
CN109432440B (zh) * 2018-11-30 2022-04-26 佛山科学技术学院 一种吡喹酮羟丙基环糊精包合物及其制备方法和应用
RU2722272C1 (ru) * 2019-04-30 2020-05-28 Общество с ограниченной ответственностью "Научно-производственная компания "СКиФФ" Средство для лечения и профилактики нематодозов и цестодозов у мелких домашних животных
WO2022034226A1 (en) * 2020-08-14 2022-02-17 Universidad De Navarra Avermectin and milbemycin compositions for inhalation
CN116744917A (zh) 2020-09-04 2023-09-12 礼蓝美国公司 适口调配物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4447414A (en) * 1982-12-21 1984-05-08 Cutter Laboratories, Inc. Carnivore anthelmintics
SE9301489D0 (sv) * 1993-04-30 1993-04-30 Ab Astra Veterinary composition
AUPM969994A0 (en) 1994-11-28 1994-12-22 Virbac S.A. Equine anthelmintic formulations
EP0959891A1 (en) * 1996-07-30 1999-12-01 Ashmont Holdings Limited Anthelmintic formulations
GB9801109D0 (en) 1998-01-20 1998-03-18 Pfizer Cyclodextrin compositions
US6207179B1 (en) 2000-05-18 2001-03-27 Phoenix Scientific, Inc. Parasiticidal formulation for animals and a method of making this formulation
US7704975B2 (en) * 2000-12-19 2010-04-27 Cephalon, Inc. Modafinil compound and cyclodextrin mixtures
ATE334987T1 (de) * 2002-03-08 2006-08-15 Bayer Healthcare Ag Artemisininderivate (endoperoxide) mit wirkung gegen parasiten
US20060205681A1 (en) * 2002-06-21 2006-09-14 Maryam Moaddeb Homogenous paste formulations
US7001889B2 (en) * 2002-06-21 2006-02-21 Merial Limited Anthelmintic oral homogeneous veterinary pastes
US20040151759A1 (en) * 2002-08-16 2004-08-05 Douglas Cleverly Non-animal product containing veterinary formulations
MXPA06012777A (es) * 2004-05-06 2007-02-14 Cydex Inc Formulaciones de sabor enmascarado que contienen sertralina y eter sulfoalquilico-ciclodextrina.
EP1771161B1 (en) * 2004-07-22 2010-04-21 Bend Research, Inc Taste masking formulation comprising the drug in a dissolution-retarded form and/or cyclodextrin in a dissolution-enhanced form
AU2007100254A4 (en) 2007-03-29 2007-05-03 Jurox Pty Ltd Improved parasiticide paste

Also Published As

Publication number Publication date
AU2008322995B2 (en) 2014-01-30
JP2011503140A (ja) 2011-01-27
US20100286154A1 (en) 2010-11-11
EP2219643A1 (en) 2010-08-25
AU2008322995A1 (en) 2009-05-22
CA2703008A1 (en) 2009-05-22
ES2385126T3 (es) 2012-07-18
EP2219643B1 (en) 2012-05-16
WO2009062939A1 (en) 2009-05-22

Similar Documents

Publication Publication Date Title
JP5319691B2 (ja) プラジカンテル、マクロライドラクトン、シクロデキストリンおよび粘稠化剤を含む駆虫ペースト
AU2009233654B2 (en) Non-animal product containing veterinary formulations
EP2268282B1 (en) Liquid formulation for deferiprone with palatable taste
CN114144172A (zh) 软咀嚼兽用剂型
EA021301B1 (ru) Фармацевтическая композиция в виде водной суспензии или полужидкой пасты, содержащая смектит
TW202412756A (zh) 包含sglt-2抑制劑之水性醫藥組合物
CN117545473A (zh) 适口兽用组合物
JP2008523024A (ja) メロキシカムを含んでなる経口用懸濁剤
TWI259082B (en) Stable ribavirin syrup formulations
BRPI0619620B1 (pt) composição veterinária oral e uso da mesma
US20220142920A1 (en) Praziquantel Formulations
EP2594258B1 (en) Oral gel comprising praziquantel
KR101297354B1 (ko) 안정하고 불쾌한 맛이 차폐된 덱시부프로펜을 함유한 투명한 시럽 조성물
RU2824778C2 (ru) Мягкая жевательная ветеринарная лекарственная форма
AU2007221747B2 (en) Medicament
GB2627797A (en) Trilostane formulation
HK1152871B (en) Liquid formulation for deferiprone with palatable taste
HK1071705B (en) Non-animal product containing veterinary formulations

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20111110

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20111110

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20130702

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20130711

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R360 Written notification for declining of transfer of rights

Free format text: JAPANESE INTERMEDIATE CODE: R360

R360 Written notification for declining of transfer of rights

Free format text: JAPANESE INTERMEDIATE CODE: R360

R371 Transfer withdrawn

Free format text: JAPANESE INTERMEDIATE CODE: R371

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

LAPS Cancellation because of no payment of annual fees